Rewriting Duchenne muscular dystrophy therapy

Cell · Published 2026-07-01 · DOI 10.1016/j.cell.2026.06.011

Authors (2)

Paloma Gonzalez-Perez, Craig Blackstone

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gonzalez-Perez, P., Blackstone, C. (2026). Rewriting Duchenne muscular dystrophy therapy. Cell. https://doi.org/10.1016/j.cell.2026.06.011

Related articles

• Multimodal imaging of gene expression, morphology, and activity of the same neuron · Cell · 2026 · Same journal
• Bridging omics and physiology to build multimodal clocks of human aging · Cell · 2026 · Same journal
• Long-term reversal of Duchenne muscular dystrophy via circular arRNA-guided exon skipping in monkeys and humans · Cell · 2026 · Same journal
• Two distinct causes contribute to the low efficiency of human pre-implantation development · Cell · 2026 · Same journal
• Coordinated RNA- and protein-templated synthesis of double-stranded DNA by a dual reverse transcriptase immune system · Cell · 2026 · Same journal
• Spatial proximity sequencing maps developmental dynamics in the Germinal Center 2332687 · Cell · 2026 · Same journal
• Condensates of the chromatin regulator ANKRD11 restrict hypertranscribed genes to safeguard development · Cell · 2026 · Same journal
• Boron-bridged GIPCs stabilize cell wall anchoring and PIN polar domains · Cell · 2026 · Same journal
• The silicon citizen naturalist · Cell · 2026 · Same journal
• Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy · Cell · 2026 · Same journal